Related Experiment Video
Updated: Jun 21, 2026
08:29
Assessment of Myofilament Ca2+ Sensitivity Underlying Cardiac Excitation-contraction Coupling
Published on: August 1, 2016
Myocardial Na,K-ATPase: Clinical aspects
1Laboratory for Molecular Cardiology, Copenhagen Heart Arrhythmia Research Centre, The Heart Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Experimental and Clinical Cardiology
|July 31, 2009
Summary
Digitalis glycosides, like digoxin, are crucial for treating heart failure by improving heart function and hemodynamics. Maintaining proper potassium levels is vital for Na,K-ATPase activity and overall cardiac health.
Area of Science:
- Cardiology
- Biochemistry
- Pharmacology
Background:
- Heart failure is associated with a significant decrease in myocardial Na,K-ATPase concentration, correlating with reduced heart function.
- Digitalis glycosides bind specifically to Na,K-ATPase, enabling its quantification and serving as a therapeutic agent in heart failure.
- Various medications used for heart failure, including diuretics and ACE inhibitors, can influence Na,K-ATPase activity and potassium homeostasis.
Purpose of the Study:
- To explore the role of Na,K-ATPase in heart failure and its modulation by therapeutic interventions.
- To investigate the impact of digitalis glycosides and other heart failure medications on Na,K-ATPase activity and potassium regulation.
- To highlight the importance of Na,K pump modulation in the context of sodium, potassium, and calcium balance in cardiac disease.
Main Methods:
- Utilizing the specific binding of digitalis glycosides to Na,K-ATPase for accurate quantification.
- Analyzing myocardial biopsies from heart failure patients to assess Na,K-ATPase concentration.
- Reviewing the effects of various drugs (diuretics, ACE inhibitors, spironolactone) and physiological conditions (hyperaldosteronism, potassium depletion) on Na,K-ATPase activity.
Main Results:
- Total Na,K-ATPase concentration is reduced by approximately 40% in heart failure patients.
- Digoxin occupies about 30% of remaining Na,K pumps during digitalization.
- Potassium loss from diuretic therapy decreases Na,K-ATPase, while ACE inhibitors may stimulate it; hyperaldosteronism also reduces activity.
Conclusions:
- Na,K-ATPase plays a critical role in heart function, and its modulation by disease and medication is significant.
- Digitalis glycosides are recommended for heart failure patients with persistent symptoms, improving hemodynamics and serving as safe oral inotropic agents.
- Maintaining extracellular potassium homeostasis is crucial, with a recommendation for resting plasma potassium levels around 4 mmol/L to optimize Na,K pump function and prevent arrhythmias.
Related Concept Videos
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
01:26Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:27Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
01:30Cardiac Action Potential
Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
01:48ATP Synthase: Mechanism
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...